Share on StockTwits
 

Carillion (LON:CLLN)‘s stock had its “hold” rating restated by equities researchers at Cantor Fitzgerald Europe in a research report issued on Monday, ARN reports. They currently have a GBX 350 ($5.75) price target on the stock. Cantor Fitzgerald Europe’s price objective would indicate a potential downside of 1.41% from the company’s current price.

Several other analysts have also recently commented on the stock. Analysts at Liberum Capital reiterated a “hold” rating on shares of Carillion in a research note to investors on Friday, January 10th. They now have a GBX 300 ($4.92) price target on the stock. Separately, analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Carillion in a research note to investors on Wednesday, December 18th. They now have a GBX 300 ($4.92) price target on the stock. Finally, analysts at RBC Capital reiterated an “outperform” rating on shares of Carillion in a research note to investors on Wednesday, December 11th. They now have a GBX 315 ($5.17) price target on the stock. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of GBX 312.87 ($5.14).

Shares of Carillion (LON:CLLN) traded up 0.42% during mid-day trading on Monday, hitting GBX 356.50. The stock had a trading volume of 921,616 shares. Carillion has a 1-year low of GBX 240.00 and a 1-year high of GBX 348.50. The stock has a 50-day moving average of GBX 317.6 and a 200-day moving average of GBX 303.0. The company’s market cap is £1.533 billion.

Carillion plc is an integrated support services company, with a portfolio of public private partnership projects and construction capabilities.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.